Lindane Lotion Rx
Generic Name and Formulations:
Various generic manufacturers
Indications for Lindane Lotion:
Treatment of scabies in patients who have failed on, or are intolerant of, other therapies. Not for prophylactic use.
Adults and Children:
Treat once only. Use least amount to cover body. <110lbs: not recommended. ≥110lbs: average size adult: 30mL; larger adult: max 60mL. Apply sparingly to dry skin; leave on for 8–12 hours then wash off thoroughly.
Uncontrolled seizure disorders. Premature infants. Norwegian (crusted) scabies, other skin conditions (eg, eczema, psoriasis, broken skin) that may increase absorption.
Potential CNS toxicity if absorbed. Children, infants, elderly, patients <110lbs: increased neurotoxicity risk. Seizure risk (eg, history of head trauma, prior seizures, CNS tumor, HIV infection, hepatic cirrhosis, abrupt alcohol/sedative withdrawal). Itching may occur or worsen after successful treatment; do not retreat. Avoid eyes. Do not swallow or misuse. Pregnancy (Cat.C), nursing mothers: not recommended.
Systemic absorption and toxicity may be increased by oils, creams, ointments. Caution with drugs that lower seizure threshold (eg, antipsychotics, antidepressants, quinolones, theophylline, cyclosporine).
Irritation, post-treatment pruritus, CNS stimulation (eg, dizziness, convulsions).
Formerly known under the brand names Gamene, Kwell, Scabene.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- Confronting Racial Disparities in Prostate Cancer Survival Outcomes
- Everolimus Plus Letrozole: An Effective First-Line Therapy for Advanced Breast Cancer
- FDA Approves Nilotinib for Pediatric Patients With CML
- Nicotinamide and Cancer
- Nivolumab Plus Ipilimumab Improves Overall Survival, ORR in Renal Cell Carcinoma
- Encorafenib, Binimetinib May Be Effective in BRAF-Mutant Melanoma